We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Hepregen Corporation and The Hamner Institutes for Health Sciences Announce Research Partnership

News   Aug 13, 2013

 
Hepregen Corporation and The Hamner Institutes for Health Sciences Announce Research Partnership
 
 
 

RELATED ARTICLES

Effects of Opioids on Driving Performance

News

A new study found that the influence of single analgesic doses of methadone and buprenorphine—two different opioids—on driving performance was mild and below the impairment threshold of a blood alcohol concentration of 0.5 mg ml-1.

READ MORE

Fluidic Analytics Raises $31m to Launch Two New Products in Lab Tools Pipeline and Unlock Biology Behind Major Diseases

News

Proteins and their behaviour are crucial to understanding how diseases develop, identifying the way that drugs interact with their targets, and developing new methods for matching the right treatment to the right patient at the right time.

READ MORE

A Better Drug to Save Mothers’ Lives During Childbirth?

News

Postpartum hemorrhaging is the world's leading cause of death for women during and after childbirth, and the third-leading cause in the United States alone. The drug 'misoprostol' although affordable, has dangerous side effects, including uterine cramping, heart attack, toxicity in the brain and spinal cord, fetal death and fetal heart abnormalities. Development of a safer drug may be on the horizon, based on new research

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE